Gattex Articles

NPS Pharma regains rights to Revestive and Preotact from Takeda

20 March 2013

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

17 October 2012

FDA posts briefing papers for review of NPS Pharma's Gattex for SBS

15 October 2012

NPS Pharma posts overall positive Gattex data, but shares plunge due to two deaths

1 November 2011

NPS Pharma soars as Gattex meets primary efficacy endpoint in Ph III study

1 February 2011

Showing 1-5 of 5 articles

Go to beginning

Previous

1

Next

Go to end